Includes nasal sprays in topical therapeutic pharmaceutical agents optometrists are authorized to use

This bill expands the range of medications optometrists can prescribe by explicitly including nasal sprays used to treat dry eye disease. Currently, optometrists are authorized to use topical therapeutic agents, but this legislation clarifies that this category now covers specific drugs administered via nasal spray for dry eye conditions. The change allows eye care professionals to prescribe these nasal sprays directly, streamlining treatment options for patients without requiring a referral to another specialist. Once signed into law, the update takes effect immediately to align with existing practices where nasal sprays are already utilized for this purpose.